Grants & Giving
Grants & Giving
At Exelixis, making a difference goes beyond developing medicines for patients. We support like-minded organizations that are dedicated to improving cancer education, outreach and advocacy. Through our giving initiatives, we extend our impact and create partnerships to benefit patients as well as the healthcare providers and researchers championing their care. We approach educational requests, sponsorships, charitable contributions and volunteerism with a generous spirit of caring, knowing that together we can do more for the communities we serve. To visit our Exelixis Request Management System, or to submit a grant, please click here.
Areas of Support
Exelixis currently supports grants and giving initiatives that fall within the certain key categories listed below:
Community Support Donations
Monetary charitable contributions to support 501(c)(3), 501(c)(4), and 501(c)(6) non-profit organizations’ initiatives or general missions in support of local community causes.
Community Support Donation proposals must be submitted at least 60 days prior to program start date, if applicable.
Healthcare-Related Charitable Contributions
Monetary charitable contributions to support 501(c)(3), 501(c)(4), and 501(c)(6) non-profit organizations’ initiatives or general missions in support of oncology and cancer awareness, patient education and advocacy, or to provide a general benefit to the healthcare community. Exelixis may not receive tangible benefits in return for such support.
Healthcare-related charitable contribution proposals must be submitted at least 60 days prior to the program start date, if applicable.
Healthcare-related charitable contributions do not include Independent Patient Assistance Foundation Donations.
Independent Patient Assistance Foundation
Monetary charitable contributions to support independent patient assistant foundations that provide financial assistance to help patients access available treatments for specific diseases or receive health care-related support.
Medical Education Requests
Support for advancing scientific discourse and improving patient care through clinical, scientific, or educational programs or activities including, but not limited to:
- Independent medical education (IME) that is either accredited continuing medical education (CME) or non-accredited CME
- Third party scientific and educational conferences and professional meetings for which no tangible benefit (exhibit booth, complimentary registrations, etc.) is provided
- Grand rounds, journal clubs, and tumor boards
Supported delivery formats include live events such as educational conferences, symposia, or meetings, enduring educational materials, and web-based or online educational activities.
Exelixis may not receive tangible benefits for a medical education request with the exception of fair recognition of support.
Medical education proposals must be submitted at least 90 days prior to the program start date and at least 60 days prior to the funding decision needed date.
General funding support of various scientific and educational activities or programs through the sponsorship and participation in activities including, but not limited to:
- Scientific conferences and meetings
- Non-profit professional societies supporting healthcare-related research and education
- Corporate council memberships
- Exhibits and medical informational booths
- Product theaters
Exelixis may receive appropriate tangible benefits in return for such support, commensurate with the amount of funding provided as part of a sponsorship.
Sponsorship proposals must be submitted at least 60 days prior to the program start date.
Exelixis welcomes proposals seeking support within the therapeutic area of oncology, with focus including, but not limited to renal cell carcinoma, hepatocellular carcinoma, thyroid cancer, prostate cancer, and lung cancer. Programs in other cancer indications or in therapeutic areas outside of oncology may be considered. Please note that not all programs can be approved, even if the request relates to the above therapeutic area and disease states.